methimazole
Selected indexed studies
- Methimazole-induced hepatotoxicity. (Endocr Pract, 2002) [PMID:12467281]
- Risk of recurrence at the time of withdrawal of short- or long-term methimazole therapy in patients with Graves' hyperthyroidism: a randomized trial and a risk-scoring model. (Endocrine, 2024) [PMID:38165576]
- Desensitization to Methimazole. (Endocr Pract, 2021) [PMID:33779553]
_Worker-drafted node — pending editorial review._
Connections
methimazole is a side effect of
Sources
- Methimazole-induced hepatotoxicity. (2002) pubmed
- Risk of recurrence at the time of withdrawal of short- or long-term methimazole therapy in patients with Graves' hyperthyroidism: a randomized trial and a risk-scoring model. (2024) pubmed
- Desensitization to Methimazole. (2021) pubmed
- Methimazole-Induced Cholestatic Jaundice: A Rare Case and Literature Review. (2025) pubmed
- Subclinical Hyperthyroidism. (2018) pubmed
- Antithyroid drugs. (2005) pubmed
- Methimazole-Induced Pancytopenia in a Patient with Graves' Disease: A Case Report and Literature Review. (2025) pubmed
- Methimazole-induced jaundice. (1973) pubmed
- Methimazole-induced arthritis. (1989) pubmed
- Methimazole embryopathy: delineation of the phenotype. (1999) pubmed